Biotechnology Stocks I Performance Guide: Intellia Therapeutics, Inc. (NTLA)
NTLA has no dividends.
Table and Chart of NTLA Performance
See what a $1,000 investment in NTLA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NTLA Returns | |
|---|---|
| Start Date | Jun-30-2016 |
| Start Price | $21.35 |
| End Date | Oct-11-2024 |
| End Price | $18.58 |
| # Prices | 101 |
| Min Date | May-31-2017 |
| Min Price | $11.46 |
| Max Date | Jun-30-2021 |
| Max Price | $161.91 |
| Total Return | -12.97% |
| Annualized Return | -1.64% |
| Current Value of $1,000 Purchase | $870 |
| Number Returns | 5,050 |
| Average Return | 115.91% |
| Number Profitable Returns | 3,251 |
| Percent Profitable Returns | 64.38% |
| Number Unprofitable Returns | 1,799 |
| Percent Unprofitable Returns | 35.62% |
| Profitable to Unprofitable Returns Ratio | 1.81 |
| NTLA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -5.510 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -514177984 |
| PE to Growth Ratio | None |
| Price to Book | 41.06 |
| PRICE DATA | |
| 52 Week High | $1.759 |
| 52 Week Low | $34.87 |
| Analyst Target Price | $-0.488 |
| 50-Day Moving Average | $17.09 |
| 200-Day Moving Average | $21.26 |
| FINANCIAL DATA | |
| Revenue per Share | $-5.48 |
| Revenue | $0 |
| Profit Margin | 49.5% |
| Return on Equity | -26.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NTLA Compare Returns with S&P 500
NTLA Trendline Chart
NTLA Moving Average Chart
NTLA Stock Return Map - See Patterns of Gains and Losses
NTLA Stock Returns/Purchase Dates